Keryx Biopharmaceuticals (KERX - Get Report) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease. This stock is trading up 6.5% at $2.15 in recent trading.
Today's Range: $2.05-$2.1852-Week Range: $1.28-$5.19 Volume: 2.1 million Three-Month Average Volume: 2.4 million >>22 Biopharma Stocks With Breakout Potential From a technical perspective, KERX is ripping to the upside here with decent volume. This move has pushed the stock into breakout territory, since shares are moving above some near-term overhead resistance at $2.12. Traders should now look for long-biased trades if KERX can manage trigger a much bigger breakout trade. That trade will hit once KERX takes out some past overhead resistance at $2.34, and then its 200-day moving average of $2.65 with high volume. Look for a sustained move or close above those levels with volume that's near or above 2.4 million shares. If we get that action soon, then KERX will enter its gap-down zone from back in April that took the stock from over $5 to below $2.